Research Articles | Page 11 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria Jun 2023 Blood Aplastic Anemia
How I Treat Paroxysmal nocturnal hemoglobinuria Jan 2021 Blood Paroxysmal Nocturnal Hemoglobinuria (PNH)
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes Jan 2019 Blood Myelodysplastic Syndromes (MDS)
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria May 2020 Blood Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Germline DDX41 mutations define a significant entity within adult MDS/AML patients Sep 2019 Blood Myelodysplastic Syndromes (MDS)
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes Sep 2020 Blood Myelodysplastic Syndromes (MDS)
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia Jun 2023 Blood Aplastic Anemia
Newly revised 2023 MDS response criteria Apr 2023 Blood Myelodysplastic Syndromes (MDS)
The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes Dec 2023 Blood Myelodysplastic Syndromes (MDS)
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes Dec 2024 Blood Myelodysplastic Syndromes (MDS)